The advanced molybdenum-based rare process experiment (AMoRE) aims to search for neutrinoless double beta decay ($$0\nu \beta \beta $$0νββ) of $$^{100}$$100Mo with $$\sim 100\,\hbox {kg}$$∼100kg of $$^{100}$$100Mo-enriched molybdenum embedded in cryogenic detectors with a dual heat and light readout. At the current, pilot stage of the AMoRE project we employ six calcium molybdate crystals with a total mass of 1.9 kg, produced from $$^{48}$$48Ca-depleted calcium and $$^{100}$$100Mo-enriched molybdenum ($$^{48{{\text {depl}}}}\hbox {Ca}^{100}\hbox {MoO}_{4}$$48deplCa100MoO4). The simultaneous detection of heat (phonon) and scintillation (photon) signals is realized with high resolution metallic magnetic calorimeter sensors that operate at milli-Kelvin temperatures. This stage of the project is carried out in the Yangyang underground laboratory at a depth of 700 m. We report first results from the AMoRE-Pilot $$0\nu \beta \beta $$0νββ search with a 111 kg day live exposure of $$^{48{{\text {depl}}}}\hbox {Ca}^{100}\hbox {MoO}_{4}$$48deplCa100MoO4 crystals. No evidence for $$0\nu \beta \beta $$0νββ decay of $$^{100}$$100Mo is found, and a upper limit is set for the half-life of $$0\nu \beta \beta $$0νββ of $$^{100}$$100Mo of $$T^{0\nu }_{1/2} > 9.5\times 10^{22}~\hbox {years}$$T1/20ν>9.5×1022years at 90% C.L. This limit corresponds to an effective Majorana neutrino mass limit in the range $$\langle m_{\beta \beta }\rangle \le (1.2-2.1)\,\hbox {eV}$$⟨mββ⟩≤(1.2-2.1)eV.
In a dedicated test setup at the Kamioka Observatory we studied pulse shape discrimination (PSD) in liquid xenon (LXe) for dark matter searches. PSD in LXe was based on the observation that scintillation light from electron events was emitted Preprint submitted to Elsevier 14 June 2011 over a longer period of time than that of nuclear recoil events, and our method used a simple ratio of early to total scintillation light emission in a single scintillation event.Requiring an efficiency of 50% for nuclear recoil retention we reduced the electron background to 7.7±1.1(stat)± 1.2 0.6 (sys)×10 −2 at energies between 4.8 and 7.2 keV ee and to 7.7±2.8(stat)± 2.5 2.8 (sys)×10 −3 at energies between 9.6 and 12 keV ee for a scintillation light yield of 20.9 p.e./keV. Further study was done by masking some of that light to reduce this yield to 4.6 p.e./keV, the same method results in an electron event reduction of 2.4±0.2(stat)± 0.3 0.2 (sys)×10 −1 for the lower of the energy regions above. We also observe that in contrast to nuclear recoils the fluctuations in our early to total ratio for electron events are larger than expected from statistical fluctuations.
XMASS-I is a single-phase liquid xenon detector whose purpose is direct de- tection of dark matter. To achieve the low background requirements necessary in the detector, a new model of photomultiplier tubes (PMTs), R10789, with a hexagonal window was developed based on the R8778 PMT used in the XMASS prototype detector. We screened the numerous component materials for their radioactivity. During development, the largest contributions to the reduction of radioactivity came from the stem and the dynode support. The glass stem was exchanged to the Kovar alloy one and the ceramic support were changed to the quartz one. R10789 is the first model of Hamamatsu Photonics K. K. that adopted these materials for low background purposes and provided a groundbreaking step for further reductions of radioactivity in PMTs. Measurements with germanium detectors showed 1.2±0.3 mBq/PMT of 226 Ra, less than 0.78 mBq/PMT of 228 Ra, 9.1±2.2 mBq/PMT of 40 K, and 2.8±0.2 mBq/PMT of 60 Co. In this paper, the radioactive details of the developed R10789 are described together with our screening methods and the components of the PMT.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.